Crispr Therapeutics shares owned by Evoke Wealth
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Evoke Wealth
from 13F filings
Historical chart of Evoke Wealth investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Evoke Wealth consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Crispr Therapeutics by Evoke Wealth
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $225k | 3.3k | 68.16 |
2023-12-31 | $207k | 3.3k | 62.60 |
2023-06-30 | $211k | 3.8k | 56.14 |
2022-09-30 | $216k | 3.3k | 65.45 |
2022-06-30 | $201k | 3.3k | 60.91 |
2022-03-31 | $207k | 3.3k | 62.73 |
2021-12-31 | $250k | 3.3k | 75.76 |
2021-09-30 | $369k | 3.3k | 111.82 |
2021-06-30 | $534k | 3.3k | 161.82 |
2021-03-31 | $402k | 3.3k | 121.82 |
2020-12-31 | $505k | 3.3k | 153.03 |
2020-09-30 | $276k | 3.3k | 83.64 |
2020-06-30 | $243k | 3.3k | 73.64 |
2020-03-31 | $140k | 3.3k | 42.41 |
2019-12-31 | $201k | 3.3k | 60.91 |